Xenon Pharmaceuticals Inc.

SEC 4 · Filed

0001193125-26-009232Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jan 9, 2026

Grant, award or other acquisition by DiFabio Andrea

Security
Restricted Share Units
Code
A
Shares
15,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-01-09",
  "direction": "A",
  "exercise_price": "0",
  "expiration": null,
  "footnotes": {
    "F2": "Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on January 9, 2027."
  },
  "owners": [
    {
      "cik": "0001692506",
      "name": "DiFabio Andrea",
      "roles": [
        "officer"
      ],
      "title": "Chief Legal Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "15000",
  "price": "0",
  "row": 2,
  "rule_10b5_1": "false",
  "security": "Restricted Share Units",
  "shares": "15000",
  "table": "II",
  "underlying_security": "Common Shares",
  "underlying_shares": "15000"
}
Insider transactionsEvent date Jan 9, 2026

Grant, award or other acquisition by DiFabio Andrea

Security
Share Option (Right to Buy)
Code
A
Shares
80,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-01-09",
  "direction": "A",
  "exercise_price": "42.15",
  "expiration": "2036-01-08",
  "footnotes": {
    "F1": "Vesting 25% on January 9, 2027, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."
  },
  "owners": [
    {
      "cik": "0001692506",
      "name": "DiFabio Andrea",
      "roles": [
        "officer"
      ],
      "title": "Chief Legal Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "80000",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "false",
  "security": "Share Option (Right to Buy)",
  "shares": "80000",
  "table": "II",
  "underlying_security": "Common Shares",
  "underlying_shares": "80000"
}